| EPIC |
EAH |
| Sector |
Pharma and Biotech |
| ISIN |
GB0032036807 |
| Market Sector |
AIM |
| Market Segment |
ASX1 |
| Main Indices |
FTSE AIM All-Share |
| Country of register |
Great Britain |
| Currency |
British Pound |
| Market Cap |
£75.21m |
| NMS |
1,500 |
| Shares in issue |
67.76m |
| Date Listed |
26-Sep-1995 |
| |
Final |
Final |
| Ex-Div |
23-Sep-21 |
26-Sep-19 |
| Paid |
22-Oct-21 |
16-Oct-19 |
| Amount |
1.00p |
7.04p |
| 15:31 |
1 @ 112.00p |
| 15:31 |
1 @ 112.00p |
| 15:31 |
1,786 @ 111.98p |
| 15:05 |
10,000 @ 111.80p |
| 14:38 |
1 @ 112.00p |
| CFO |
Christopher Wilks |
| CEO |
David Hallas |
Top of Page
You are here:
research